MedTrace Logo

Identification of Genomic Predictors of Adverse Events After Cardiac Surgery

NCT01258231 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2024-08-22

No results posted yet for this study

Summary

This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure.

Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Texas Heart Institute

    collaborator OTHER

  • University of Texas Southwestern Medical Center

    collaborator OTHER

  • Johns Hopkins University

    collaborator OTHER

  • Brigham and Women's Hospital

    lead OTHER

Principal Investigators

  • Jochen D Muehlschlegel, MD MMSc, MPH · Brigham and Women's Hospital

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-08-31
Primary Completion
2030-08-31
Completion
2030-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01258231 on ClinicalTrials.gov